Skip to main content
Top
Published in: Journal of Nuclear Cardiology 3/2021

01-06-2021 | Cardiac Amyloidosis | Case Presentation Corner

Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report

Authors: Yvan R. Persia-Paulino, MD, Javier Cuevas-Perez, MD, Rodrigo Fernandez-Asensio, MD, Alejandro Junco-Vicente, MD, Jose Rozado-Castano, MD, PhD, Santiago Colunga, MD, Helena Cigarran, MD, Juan Calvo, MD, Alfredo Laverde, MD, Osiris Persia, MD, Esmeralda Capin-Sampedro, MD

Published in: Journal of Nuclear Cardiology | Issue 3/2021

Login to get access

Abstract

We present a case of a 40-year-old Spanish man with cardiac amyloidosis in which a Tc-99m-3,3-diphosphono-1,2-propanodicarboxylic acid (Tc-99m-DPD) scintigraphy was strongly suggestive of cardiac amyloidosis by transthyretin (ATTR) but endomyocardial biopsy (EB) analyzed by immunohistochemistry demonstrated a light chain amyloidosis (AL). Even though the Tc-99m-DPD has proven in different published papers that has high sensibility and specificity for differentiating AL and ATTR cardiac amyloidosis, we present an unusual case of an AL cardiac amyloidosis with a Perugini grade 3 on the scintigraphy. Diagnostic approach of cardiac amyloidosis following consensus documents is discussed to avoid diagnostic mistakes based on imaging techniques.
Literature
1.
go back to reference Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: Assessment, diagnosis, and referral. Heart 2011;97:75-84.CrossRef Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: Assessment, diagnosis, and referral. Heart 2011;97:75-84.CrossRef
2.
go back to reference Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, et al. Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee Amyloid nomenclature. Mayo Clin Proc 2019;25:215-9. Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, et al. Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee Amyloid nomenclature. Mayo Clin Proc 2019;25:215-9.
3.
go back to reference Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses. Disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-1212. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses. Disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-1212.
4.
go back to reference Lachman HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gilmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361-71.CrossRef Lachman HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gilmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361-71.CrossRef
5.
go back to reference Rahman JE, Helou EF, Gelzer-bell R, Thompson RE, Kuo C, Rodriguez ER, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43:410-5.CrossRef Rahman JE, Helou EF, Gelzer-bell R, Thompson RE, Kuo C, Rodriguez ER, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43:410-5.CrossRef
6.
go back to reference Perugini E, Guidalotti PL, Salvi F, Cooke RMT, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46:1076-84.CrossRef Perugini E, Guidalotti PL, Salvi F, Cooke RMT, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46:1076-84.CrossRef
7.
go back to reference Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99mTc-pyrophosphate scintigraphy for differentiating light- chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195-201.CrossRef Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99mTc-pyrophosphate scintigraphy for differentiating light- chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195-201.CrossRef
8.
go back to reference Lee GY, Kim K, Choi J, Kim SJ, Kim J, Choe YH, et al. Cardiac amyloidosis without increased left ventricular wall thickness. Mayo Clin Proc 2019;89:781-9.CrossRef Lee GY, Kim K, Choi J, Kim SJ, Kim J, Choe YH, et al. Cardiac amyloidosis without increased left ventricular wall thickness. Mayo Clin Proc 2019;89:781-9.CrossRef
9.
go back to reference Hutt DF, Quigley A, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Hear J 2014;15:1289-98. Hutt DF, Quigley A, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Hear J 2014;15:1289-98.
10.
go back to reference Habib G, Bucciarelli-ducci C, Caforio ALP, Cardim N, Derumeaux G, Charron P, et al. Multimodality imaging in restrictive cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardi. Eur Hear J 2017;18:1090-1. Habib G, Bucciarelli-ducci C, Caforio ALP, Cardim N, Derumeaux G, Charron P, et al. Multimodality imaging in restrictive cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardi. Eur Hear J 2017;18:1090-1.
Metadata
Title
Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report
Authors
Yvan R. Persia-Paulino, MD
Javier Cuevas-Perez, MD
Rodrigo Fernandez-Asensio, MD
Alejandro Junco-Vicente, MD
Jose Rozado-Castano, MD, PhD
Santiago Colunga, MD
Helena Cigarran, MD
Juan Calvo, MD
Alfredo Laverde, MD
Osiris Persia, MD
Esmeralda Capin-Sampedro, MD
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 3/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02107-2

Other articles of this Issue 3/2021

Journal of Nuclear Cardiology 3/2021 Go to the issue